Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sucralfate (1gm) Tablet
Therapeutic Category
Antacid, Gastroenterology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Sucraziff Tablet containing Sucralfate is used for the management of gastric ulcers, acidity, and stomach lining irritation. It helps protect the ulcer surface and supports healing of the gastric mucosa.
Sucralfate works by forming a protective barrier over damaged stomach lining, shielding it from acid and digestive enzymes, thereby promoting faster healing.
The tablet is widely prescribed in gastroenterology practice for ulcer management and acid-related disorders, leading to consistent prescription demand.
With increasing prevalence of lifestyle-related acidity and gastric disorders, this product offers strong business potential for retailers and distributors. Its mucosal protective action, broad clinical relevance, and steady market demand make it a reliable product for growth in the gastroenterology segment.
Some patients may experience constipation, dry mouth, nausea, or mild abdominal discomfort. Rarely, allergic reactions may occur.
Sucraziff Tablet is indicated for gastric ulcers, duodenal ulcers, gastritis, acid peptic disease, and prevention of stress-related mucosal damage. It helps relieve stomach pain, reduce acidity-related discomfort, and support healing of ulcers.
This medicine should be used under medical supervision. It should be taken on an empty stomach for best effect. Avoid taking antacids within 30–60 minutes of this medicine unless advised by a doctor.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Lactulose 15 ml contains lactulose concentrate 66.7% in 6 gm Syrup
Composition : Ayurvedic Constipation Syrup
Composition : Aceclofenac (200mg) + Rabeprazole (20mg) Capsule
Composition : Acotiamide (100mg) Tablet
Composition : Acotiamide (300mg) Tablet
Composition : Magaldrate I.P. 400mg + Simethicone I.P. 20mg (Mango & Mint Flavour)
Composition : Magaldrate I.P. 480mg + Simethicone I.P. 20mg + Oxetacaine B.P. 10mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Sucraziff Tablet, containing Sucralfate 1gm, has strong demand in the gastroenterology segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ulcer and gastric care portfolios.
Medical distributors and agencies can benefit from the consistent demand for gastroprotective therapy used in gastric ulcers, duodenal ulcers, gastritis, acid-related irritation, and mucosal protection. Sucralfate forms a protective barrier over ulcers, strengthening a comprehensive gastro care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sucraziff Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady gastro prescription demand, hospital usage, reliable supply chain support, and good margins when partnering for Sucraziff Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Sucraziff Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.